CENTRAL TIME ZONE During this webinar, an expert will take a look at the causes and symptoms of All About SCA35, the typical diagnostic journey for those affected, what to expect for clinical care, and an overview of current research into the disease. Register: Click here. Other Webinars NAF hosts educational webinars about Ataxia presented

CENTRAL TIME ZONE Join Biogen for a webinar on Thursday, August 28, at noon Eastern Time where Nicolas Folschweiller, PhD., Senior Medical Director, Clinical Development – Neuromuscular Development Unit, at Biogen, will share information about the upcoming BRAVE study: a global Phase 3 pediatric study for omaveloxolone. Anyone considering participating in a clinical trial or trying a new

CENTRAL TIME ZONE This webinar will provide information about Arrowhead Pharmaceuticals’ ongoing Phase 1 study of ARO-ATXN2 in patients with Spinocerebellar Ataxia Type 2 (SCA2), including the rationale for an siRNA therapeutic approach, an overview of the study design and eligibility requirements for participation, and how patients can contact sites to learn more. Register: Click

CENTRAL TIME ZONE During this webinar, an expert will discuss Sialidosis, the typical diagnostic journey for those affected, what to expect for clinical care, and an overview of current research

CENTRAL TIME ZONE Discover how specialized care can transform the Ataxia journey. Join us for an inside look at NAF’s Ataxia Centers of Excellence (ACE) program—which recognizes regional hubs dedicated to delivering world-class care, advancing clinical research, and providing vital education for people living with Ataxia and their families. In this session, Kelsey Trace, OTD,